SEC Form 4 · accession 0001144204-18-033676
FENNEC PHARMACEUTICALS INC. · FENC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chris A Rallis
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 10:40 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.93 | Jun 8, 2018 | A | 20,000 | A | Jun 8, 2018 | Jun 8, 2025 | Common Shares | 20,000 | 20,000 | D |
Explanation of responses
- F1On June 8, 2018, Chris A. Rallis was granted an incentive stock option to purchase 20,000 common shares of the Issuer pursuant to the Issuer's Amended and Restated Stock Option Plan. The option is 100% vested on the date of grant.